ADAMTS13 and graft versus host disease: Blocking binding to VWF (A2) or cleaving VWF (ADAMTS13) at the time of endothelial injury was the rationale for our experimental approach of giving ADAMTS13 before radiation and A2 at the time of transplant to target homing of T cells to reduce the severity of tissue injury in GVHD.